Literature DB >> 7798686

A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.

H Wang1, R Lottenberg, M D Boyle.   

Abstract

Acquisition of plasmin(ogen) by group A streptococci occurs by two distinct pathways. In addition to the well-characterized direct interaction of plasmin with cell-surface receptors on group A streptococci, a second pathway dependent on streptokinase and a nonplasminogen factor(s) present in human plasma was identified. The role of streptokinase in the second pathway was not merely as a plasminogen activator, since substitution of the plasminogen activator urokinase did not result in the capture of plasmin(ogen) by bacteria in the presence of plasminogen-depleted plasma. However, if streptokinase was added to plasmin that had been generated by treatment of plasminogen with urokinase, the ability of the bacteria to capture plasmin in the presence of plasminogen-depleted plasma was restored. Fibrinogen present in human plasma was identified as the major factor required for streptokinase-dependent uptake of plasmin(ogen) by group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798686     DOI: 10.1093/infdis/171.1.85

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.

Authors:  H S Courtney; S Liu; J B Dale; D L Hasty
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.

Authors:  H Fuchs; M M Simon; R Wallich; M Bechtel; M D Kramer
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 3.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

4.  Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.

Authors:  B Schroeder; M D Boyle; B R Sheerin; A C Asbury; R Lottenberg
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo.

Authors:  M D Svensson; U Sjöbring; D E Bessen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies.

Authors:  H Sun
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection.

Authors:  Fiona C McKay; Jason D McArthur; Martina L Sanderson-Smith; Sandra Gardam; Bart J Currie; Kadaba S Sriprakash; Peter K Fagan; Rebecca J Towers; Michael R Batzloff; Gursharan S Chhatwal; Marie Ranson; Mark J Walker
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Defining the structural basis of human plasminogen binding by streptococcal surface enolase.

Authors:  Amanda J Cork; Slobodan Jergic; Sven Hammerschmidt; Bostjan Kobe; Vijay Pancholi; Justin L P Benesch; Carol V Robinson; Nicholas E Dixon; J Andrew Aquilina; Mark J Walker
Journal:  J Biol Chem       Date:  2009-04-10       Impact factor: 5.157

10.  Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.

Authors:  Johan Waldemarsson; Margaretha Stålhammar-Carlemalm; Charlotta Sandin; Francis J Castellino; Gunnar Lindahl
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.